Santos David A
SEC CIK 1820066 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | EVP, Chief Commercial Off | 61.6K | — | $109.3K | 12 | 2022-01-24 | 2026-09-01 |
Most active insiders at RIGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ali-Jackson Kamil | Dir | — | $160.4K |
| 2 | MOOS WALTER H | Dir | — | $145.4K |
| 3 | Rojkjaer Lisa | EVP, Chief Medical Off | — | — |
| 4 | Santos David A | EVP, Chief Commercial Off | — | — |
| 5 | HANNAH ALISON L. | EVP, Chief Medical Off | — | — |
| 6 | Furey Raymond J. | EVP, GC, CCO, Corp Sec | — | — |
| 7 | Schorno Dean L | EVP, CFO | — | — |
| 8 | Frohlich Mark W | Dir | — | — |
| 9 | Wasman Jane | Dir | — | — |
| 10 | LAPOINTE ANTHONY GREGG | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 19:01 | 2026-09-01 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | F - Tax | $47.50 | -874 | 61.6K | -1% | -$41.5K | |
| 2026-06-03 18:02 | 2026-06-01 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | F - Tax | $29.86 | -874 | 62.0K | -1% | -$26.1K | |
| 2026-02-19 | 2026-02-17 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | A - Grant | $0.00 | +19.4K | 62.9K | +45% | $0 | |
| 2026-02-12 | 2026-02-10 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | F - Tax | $34.62 | -3,546 | 43.4K | -8% | -$122.8K | |
| 2026-02-04 | 2026-02-02 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | F - Tax | $36.01 | -5,718 | 47.0K | -11% | -$205.9K | |
| M | 2025-02-06 | 2025-02-04+ | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | S - Sale | $21.38 | -3,921 | 51.7K | -7% | -$83.8K |
| D | 2025-01-31 | 2025-01-29 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | A - Grant | $0.00 | +19.7K | 55.6K | +55% | $0 |
| M | 2024-02-06 | 2024-02-02+ | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | S - Sale | $1.14 | -14.5K | 349.1K | -4% | -$16.5K |
| D | 2024-01-25 | 2024-01-23 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | A - Grant | $0.00 | +209.0K | 363.6K | +135% | $0 |
| 2023-02-06 | 2023-02-02 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | S - Sale | $1.66 | -5,388 | 144.6K | -4% | -$8,944 | |
| D | 2023-01-30 | 2023-01-26 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | A - Grant | $0.00 | +80.0K | 150.0K | +114% | $0 |
| D | 2022-01-26 | 2022-01-24 | RIGL | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Off | A - Grant | $0.00 | +50.0K | 60.0K | +500% | $0 |
Purchase Sale Sale after option exercise All abbreviations